Analystreport

Idera Pharmaceuticals Inc (NASDAQ: IDRA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Idera Pharmaceuticals, Inc.  (IDRA) 
Last idera pharmaceuticals, inc. earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.iderapharma.com/investor-overview